ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Alarm.com Holdings Inc

Alarm.com Holdings Inc (0HC2)

42.66
0.00
(0.00%)
Closed July 30 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
42.66
Bid
0.00
Ask
0.00
Volume
2,805
0.00 Day's Range 0.00
42.66 52 Week Range 42.66
Market Cap
Previous Close
42.66
Open
-
Last Trade
15
@
70.17
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,010
Shares Outstanding
49,988,000
Dividend Yield
-
PE Ratio
43.30
Earnings Per Share (EPS)
1.62
Revenue
881.68M
Net Profit
81.04M

About Alarm.com Holdings Inc

Sector
Prepackaged Software
Industry
Prepackaged Software
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alarm.com Holdings Inc is listed in the Prepackaged Software sector of the London Stock Exchange with ticker 0HC2. The last closing price for Alarm.com was $42.66. Over the last year, Alarm.com shares have traded in a share price range of $ 42.66 to $ 42.66.

Alarm.com currently has 49,988,000 shares outstanding. The market capitalization of Alarm.com is $2.13 billion. Alarm.com has a price to earnings ratio (PE ratio) of 43.30.

0HC2 Latest News

NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression

NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression PR Newswire CAMBRIDGE...

NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug

NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as...

NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results

NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass., June 24, 2024 Following positive 6-month clinical outcomes from phase 2b...

NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal

NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal PR Newswire CAMBRIDGE, Mass., June 21, 2024 CAMBRIDGE, Mass., June 21, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd...

NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit

NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit PR Newswire CAMBRIDGE, Mass., May 20, 2024 CAMBRIDGE, Mass., May 20, 2024...

NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning

NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning PR Newswire CAMBRIDGE, Mass., May 14, 2024 PhaseV's Causal Machine Learning Predicts...

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients PR...

NeuroSense Announces First Quarter 2024 Business Update

NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass., May 2, 2024 CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN...

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease PR Newswire CAMBRIDGE, Mass., April 22, 2024 CAMBRIDGE...

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting PR Newswire CAMBRIDGE, Mass., April...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10042.6642.6642.6612042.66DE
40042.6642.6642.6611242.66DE
120042.6642.6642.66501042.66DE
260042.6642.6642.66253242.66DE
520042.6642.6642.66148442.66DE
1560042.6642.6642.66111542.66DE
2600042.6642.6642.66107342.66DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UKOGUk Oil & Gas Plc
0.0855p
(205.36%)
11.53B
RENXRenalytix Plc
17.50p
(29.63%)
1.06M
MKAMkango Resources Ltd
5.75p
(25.00%)
12.22M
NOGNostrum Oil & Gas Plc
6.30p
(23.53%)
3.09k
DESTDestiny Pharma Plc
2.75p
(22.22%)
1.45M
NTOGNostra Terra Oil And Gas Company Plc
0.0335p
(-59.39%)
414.34M
PFCPetrofac Limited
16.15p
(-26.59%)
16.71M
TUNTungsten West Plc
2.75p
(-22.97%)
719.49k
CLAICel Ai Plc
0.095p
(-17.39%)
16.97M
CGHChaarat Gold Holdings Ltd
0.225p
(-16.67%)
2.19M
UKOGUk Oil & Gas Plc
0.0855p
(205.36%)
11.53B
INSPInspirit Energy Holdings Plc
0.01p
(5.26%)
2.19B
SYMESupply@me Capital Plc
0.0127p
(10.43%)
1.42B
RRRRed Rock Resources Plc
0.0525p
(11.70%)
1.05B
GWMOGreat Western Mining Corporation Plc
0.0515p
(14.44%)
642.92M

Discussion

View Full Feed
hookrider hookrider 3 minutes ago
rooster: Trump & Vance The Weird-O's!!!!!!
Bright Boy Bright Boy 8 minutes ago
Andrew Left arraigned this afternoon:

https://www.bloomberg.com/news/articles/2024-07-30/andrew-left-pleads-not-guilty-setting-up-fight-over-short-sales

This is just the beginning!The irony is that Andrew is now the "BAIT" to capture his fellow predators instead of the
NWBO
palaypu0406 palaypu0406 10 minutes ago
yes Karlacorn, It is..
ITUP
carlson carlson 10 minutes ago
What??? Soon??? How soon???
NSAV
karlacorn3 karlacorn3 12 minutes ago
Thanks, Laxmi. By "Circular" you are referring to the Grant Release Notice, correct?
K
ITUP
DogsOverPeople DogsOverPeople 14 minutes ago
Hhahhahahhahahahahahhahahhahahhahhahahahhahahahahahhahahaha
UATG
skitahoe skitahoe 17 minutes ago
I was at my neurologist's today and happened to ask her if she was familiar with AVXL's Alzheimer's drug, she hadn't. I told her it slowed brain shrinkage in the trial, that interested her, but she indicated it must be approved. I told her they were going for it in Europe first and she told me tha
AVXL NWBO
IH Geek [Tom] IH Geek [Tom] 17 minutes ago
How does this work? Shouldn't it be sorted by the highest percentage change on down to the lowest of the Top Gainers?

I'm not following this, please advise, thanks! I have Real Time... 😺

https://ih.advfn.com/markets/nasdaq/premarket/gainers

HoldEm777 HoldEm777 18 minutes ago
All they have to do in my opinion is prove CIVET USA is not BS. Produce anything at all showing it’s real and Emilia actually owned it as they say. But they are building a story on a foundation that does not exist
NWPN
Acme Investments Acme Investments 18 minutes ago
First things first!!
BCAP
palaypu0406 palaypu0406 18 minutes ago
Dear Karlacorn,
Circular will be released today...
Budget, I have already circulated the rough budget to the staff and internal group blog...
But we need to now incorporate sales and inventory adjustments given the underwriting commitment from the banking group..

ITUP
sharkey1 sharkey1 19 minutes ago
Update on the Accord trial
https://www.pacermonitor.com/public/case/53616923/Purdue_Pharma_LP_et_al_v_Accord_Healthcare_Inc_et_al
ELTP
georgejjl georgejjl 19 minutes ago
The shelf offering allows for partnership negotiations from a strong financial position when appropriate.

Good luck and GOD bless,
AVXL
PowrrrPlayz PowrrrPlayz 19 minutes ago
Over the last 7 years RH has run a tsxv ponzi scheme. We are all still here because we don't want to believe that RH bamboozled us and we are all still emotionally tied to our lost money. One major retail investor left licking his wounds but at least he was able to uncouple himself from the scheme o
SEV
ipiros ipiros 20 minutes ago
That's what I thought it said when I took a quick glance at the tweet from MMG. Busted! Need a pic to intensify the ridicule.
HIRU
RickNagra RickNagra 21 minutes ago
Oh wow. I’m expecting a massive pop today. There can be no doubt. I am a bit of a genius if I don’t say so myself. So here we go. Whales will arrive early and the whales will come to our rescue. We are obviously headed for the moon. The moon is lovely this time of year. Please be prepared.
DBMM
arizona1 arizona1 21 minutes ago
😍🥰😍🥰😍🥰😍🥰😍🥰😍😍🥰😍🥰😍🥰😍🥰😍🥰😍😍🥰😍🥰😍🥰😍🥰😍🥰😍&#x
Welcome2Pinkyland Welcome2Pinkyland 24 minutes ago
Gitalife- if you want to whine about the otc -whine to the SEC, FINFRA, otcmarkets and other agencies that have approved and sanctioned these stocks for trading.
HIRU
IH Geek [Tom] IH Geek [Tom] 25 minutes ago
@lucky, mydog - no plans to do that.

Also, user #113?? 👏

....and 👴
newmedman newmedman 26 minutes ago
Yeah, I'm batshit crazy incase you haven't heard by now.

I should have been locked in an asylum years ago. Then I wouldn't be out roaming the streets, much to your chagrin.
cadillacdave cadillacdave 26 minutes ago
News would be welcomed, for sure.

The price dropped down low, but not many shares available. But keep trying, you may get lucky and scoop up some shares on the cheap.
WDDD
marknet marknet 27 minutes ago
You know you really have a good ticker on your hands when all the trolls are out in full force trying to scare (save) us. This will hit .01 only question is a matter of when.
HIRU
skitahoe skitahoe 27 minutes ago
You're right, investors comments won't move the regulators in approving a stock. There is another consideration in which bashers, stock manipulators, the MM's with their spoofing, etc. might effect the time to approval. If they're successful in keeping the share price down, the company may choose
NWBO
gitreal gitreal 27 minutes ago
Joel Natario's involvement here guarantees there is something illegal going on. He's got a long, long history of scamming and stealing.
HIRU
hump4 hump4 27 minutes ago
I never saw the video. My wife saw it ans alerted me to look into it. Was it 10 years ago?
NWBO

Your Recent History

Delayed Upgrade Clock